Laxmi Dental IPO Day 3 Live Updates: Subscription Soars to 113.97 Times; GMP, Review, and More Insights
The initial public offering (IPO) of Laxmi Dental Ltd has gained substantial traction on its third day of subscription. As of 3:30 PM on January 15, 2025, the IPO has been subscribed 113.97 times. The most recent updates from BSE data show that the total bids for the offer have reached 1,01,98,33,782 shares against 89,70,371 shares on offer.
Subscription Details:
- Retail Investors: 73.18 times subscribed
- Non-Institutional Investors: 147.33 times subscribed
- Qualified Institutional Buyers (QIBs): 110.38 times subscribed
The IPO, which opened on January 13, 2025, has raised interest from various investor categories, highlighting strong demand across the board.
Key IPO Facts:
- Price Band: ₹407 - ₹428 per share
- Total Issue Size: ₹698.06 crore (comprising ₹138 crore from fresh issuance and ₹560 crore from an offer for sale)
- Offer for Sale (OFS): Approximately 1.31 crore equity shares
Laxmi Dental's IPO is seen as a significant opportunity, especially given the company's position in the growing dental industry, with a diversified product portfolio that includes crowns, bridges, aligners, and pediatric dental products.
Expert Reviews:
- Master Capital Services recommends a "SUBSCRIBE" rating, citing Laxmi Dental’s leading position in the fragmented dental products market. The company's ability to scale operations and offer innovative products is a major draw for long-term investors.
- Mehta Equities offers a "SUBSCRIBE" suggestion as well, highlighting the company's niche market segment and international reach, but notes that the valuation at the upper price band seems aggressively priced.
- Nirmal Bang suggests a "SUBSCRIBE" for long-term growth, noting that the IPO is priced reasonably considering the strong market dynamics and Laxmi Dental’s expansion plans.
Risk Factors:
- Geographic Concentration: Manufacturing facilities are concentrated in Mumbai and surrounding regions, which could expose the company to risks related to disruptions in this area.
- Regulatory Risks: As with all healthcare-related businesses, compliance with dental and healthcare standards is crucial, and any lapses may negatively impact operations.
GMP (Grey Market Premium):
The GMP for Laxmi Dental IPO is reported to be strong, suggesting positive sentiment among traders and retail investors.
As the IPO progresses into its final day, investors are closely watching the developments, particularly given the company’s significant market position in India’s rapidly growing dental products sector.
Reference from:-https://www.livemint.com/market/ipo/laxmi-dental-ipo-day-3-live-updates-issue-booked-16-03-times-so-far-check-gmp-subscription-status-review-more-11736909804907.html